Eucrisa

Drug - Eucrisa™ (crisaborole) [Anacor]

June 2017

Therapeutic area - Atopic Dermatitis

Approval criteria

• Must be 2 years of age or older AND
• Have a diagnosis of atopic dermatitis AND
• Be prescribed by a dermatologist AND prescriber’s specialty must be provided at time of request AND
• Trial and failure of TWO topical corticosteroids AND ONE topical calcineurin inhibitors OR
• Trial of TWO topical corticosteroids or a contraindication to topical steroid use. Contraindications include:
  • Treatment of sensitive areas (face, anogenital, skin folds)
  • Steroid induced atrophy
  • Long-term uninterrupted use AND
• Trial of ONE topical calcineurin inhibitor or a contraindication to topical calcineurin use. Contraindications include:
  • Severely impaired skin barrier (Netherton Syndrome)
  • Risk/Presence of malignancy

Quantity limits

60 g or 100 g tube: one tube per 34 days

Questions?

MHCP Provider Call Center 651-431-2700 or 800-366-5411